XML 77 R56.htm IDEA: XBRL DOCUMENT v3.25.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)
12 Months Ended
Jun. 02, 2025
$ / shares
Dec. 31, 2025
USD ($)
installment
reporting_unit
$ / shares
Dec. 31, 2024
USD ($)
$ / shares
Dec. 31, 2023
USD ($)
$ / shares
Oct. 24, 2025
USD ($)
Dec. 01, 2021
USD ($)
Concentration Risk [Line Items]            
Forward split of common stock (in percentage) 1.5          
Common stock, par or stated value per share (in USD per share) | $ / shares $ 0.0001          
Reduction in fair value of earnout   $ 0 $ (5,659,000) $ (3,874,000)    
Embedded derivatives   0 2,723,000      
Prepaid expense, current   26,000,000.0 10,800,000      
Prepaid expense for services, current   16,100,000 8,500,000      
Impairment of intangible assets   $ 0 0 0    
Number of reporting units | reporting_unit   7        
Impairment losses   $ 0 3,594,000 0    
Net sales   $ (166,419,000) $ (144,180,000) $ (136,062,000)    
Diluted (in dollars per share) | $ / shares   $ (2.89) $ (7.01) $ (3.65)    
Stock-based awards vest (in percentage)   25.00%        
Monthly installments | installment   36        
Grant date   three years        
Gross research and development costs   $ 19,000,000.0 $ 13,000,000.0 $ 18,500,000    
Government assistance, design and manufacture of Starlab           $ 217,500,000
Government assistance, operating expense, decrease   $ 6,200,000 $ 5,400,000 $ 37,000,000.0    
Government Assistance, Operating Expense, Decrease (Increase), Statement of Income or Comprehensive Income [Extensible Enumeration]   Research and development Research and development Research and development    
Government assistance, asset, decrease, current   $ 54,000,000.0 $ 54,900,000 $ 26,900,000    
Marketing costs   $ 3,200,000 $ 1,000,000.0 $ 700,000    
Government Assistance, Asset, Decrease, Current, Statement of Financial Position [Extensible Enumeration]   Property and equipment, net Property and equipment, net Property and equipment, net    
First anniversary            
Concentration Risk [Line Items]            
Stock-based awards vest (in percentage)   33.00%        
Second anniversary            
Concentration Risk [Line Items]            
Stock-based awards vest (in percentage)   33.00%        
Third anniversary            
Concentration Risk [Line Items]            
Stock-based awards vest (in percentage)   33.00%        
PF Adj            
Concentration Risk [Line Items]            
Net EAC adjustments   $ 11,100,000 $ 2,200,000 $ 1,700,000    
Net sales   $ 5,100,000        
Aggregate adjustment of revenue     $ 5,200,000 $ 3,900,000    
Diluted (in dollars per share) | $ / shares   $ (0.40) $ (0.58) $ (0.47)    
2024 Convertible Notes            
Concentration Risk [Line Items]            
Embedded derivatives   $ 3,100,000        
Fair Value, Inputs, Level 3 | Selling, General and Administrative Expenses            
Concentration Risk [Line Items]            
Reduction in fair value of earnout     $ 5,700,000 $ 3,300,000    
Measurement Input, Conversion Price | Fair Value, Inputs, Level 3            
Concentration Risk [Line Items]            
Mandatory conversion discount rate (in percentage)   0.150        
Measurement Input, Discount Rate | Fair Value, Inputs, Level 3            
Concentration Risk [Line Items]            
Mandatory conversion discount rate (in percentage)   0.158        
Measurement Input, Qualified Financing | Fair Value, Inputs, Level 3            
Concentration Risk [Line Items]            
Mandatory conversion discount rate (in percentage)   0.750        
ExoTerra            
Concentration Risk [Line Items]            
Contingent consideration         $ 7,400,000  
ExoTerra | Fair Value, Inputs, Level 3            
Concentration Risk [Line Items]            
Contingent consideration   $ 21,000,000.0        
Optical Physics Company, Inc. | Fair Value, Inputs, Level 3            
Concentration Risk [Line Items]            
Contingent consideration   3,000,000.0        
ZIN Technologies, Inc | Fair Value, Inputs, Level 3            
Concentration Risk [Line Items]            
Contingent consideration   10,300,000        
U.S. Government            
Concentration Risk [Line Items]            
Net sales   $ (143,203,000) $ (121,025,000) $ (93,473,000)    
U.S. Government | Revenue Benchmark | Customer Concentration Risk            
Concentration Risk [Line Items]            
Concentration risk (in percentage)   86.00% 83.90% 69.00%    
U.S. Government | Accounts Receivable | Customer Concentration Risk            
Concentration Risk [Line Items]            
Concentration risk (in percentage)   68.60% 76.30% 83.00%